Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Thanyarat Wongwananuruk, Nalinee Panichyawat, Tachjaree Panchalee, Preeyaporn Jirakittidul, Surasak Angsuwathana, Korakot Sirimai, Manopchai Thamkhantho & Gessuda Chiravacharadej. (2020) Comparison of change in body weight between contraception containing 30-μg ethinylestradiol/2-mg chlormadinone acetate or 30-μg ethinylestradiol/3-mg drospirenone: a randomised controlled trial. The European Journal of Contraception & Reproductive Health Care 25:1, pages 43-48.
Read now
Read now
Carlo Bastianelli, Manuela Farris, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism. Expert Review of Clinical Pharmacology 10:3, pages 315-326.
Read now
Read now
J. Spona, N. Binder, K. Höschen & W. Feichtinger. (2008) Contraceptive efficacy and safety of a low-dose oral contraceptive, (0.03 mg ethinyl oestradiol and 2 mg chlormadinone acetate) Belara®, over three medication cycles. The European Journal of Contraception & Reproductive Health Care 13:1, pages 39-48.
Read now
Read now
Stefano Lello, Grazia Primavera, Laura Colonna, Giorgio Vittori, Francesca Guardianelli, Roberto Sorge & Desanka Raskovic. (2008) Effects of two estroprogestins containing ethynilestradiol 30 mug and drospirenone 3 mg and ethynilestradiol 30 mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Gynecological Endocrinology 24:12, pages 718-723.
Read now
Read now
Articles from other publishers (13)
Hosna Mohammad Sadeghi, Ida Adeli, Daniela Calina, Anca Oana Docea, Taraneh Mousavi, Marzieh Daniali, Shekoufeh Nikfar, Aristidis Tsatsakis & Mohammad Abdollahi. (2022) Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. International Journal of Molecular Sciences 23:2, pages 583.
Crossref
Crossref
Katrin Roth, Hans Peter Zahradnik & Wolfgang R. Schäfer. (2019) Effects of different progestins on prostaglandin biosynthesis in human endometrial explants. Contraception 99:1, pages 61-66.
Crossref
Crossref
Unnop Jaisamrarn & Somsook Santibenchakul. (2018) A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial. Contraception and Reproductive Medicine 3:1.
Crossref
Crossref
Ayse Nur Aksoy, Ilay Gözükara & Suna Kabil Kucur. (2014)
Evaluation of the efficacy of
Fructus agni casti
in women with severe primary dysmenorrhea: A prospective comparative Doppler study
. Journal of Obstetrics and Gynaecology Research 40:3, pages 779-784.
Crossref
Crossref
Aida Hanjalic-Beck, Wolfgang R. Schäfer, Wolfgang R. Deppert, Lara Fischer, Antonia Stein, Laura Seebacher, Akou Seli von Gradowski, Johanna Stuckenschneider & Hans P. Zahradnik. (2012) Chlormadinone acetate suppresses prostaglandin biosynthesis in human endometrial explants. Fertility and Sterility 98:4, pages 1017-1022.
Crossref
Crossref
Aurora Guerra-Tapia & Blanca Sancho Pérez. (2011) Ethinylestradiol/Chlormadinone Acetate. American Journal of Clinical Dermatology 12, pages 3-11.
Crossref
Crossref
Gunther Göretzlehner, Susanne Waldmann-Rex & Georg A.K. Schramm. (2011) Extended Cycles with the Combined Oral Contraceptive Chlormadinone Acetate 2 mg/Ethinylestradiol 0.03 mg. Clinical Drug Investigation 31:4, pages 269-277.
Crossref
Crossref
Jürgen Spona, Natascha Binder, Kornelia Höschen & Wilfried Feichtinger. (2010) Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles. Fertility and Sterility 94:4, pages 1195-1201.
Crossref
Crossref
Ulrich H. Winkler, Petra Röhm & Kornelia Höschen. (2010) An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables. Contraception 81:5, pages 391-400.
Crossref
Crossref
Sabine Anthuber, Georg A.K. Schramm & Marie-Luise S. Heskamp. (2010) Six-Month Evaluation of the Benefits of the Low-Dose Combined Oral Contraceptive Chlormadinone Acetate 2 mg/Ethinylestradiol 0.03 mg in Young Women. Clinical Drug Investigation 30:4, pages 211-220.
Crossref
Crossref
L. Paris, N. Paillocher, G. Simon, J.-F. Ledigabel, L. Catala & P. Descamps. (2008) Dismenorreas. EMC - Ginecología-Obstetricia 44:4, pages 1-10.
Crossref
Crossref
L. Paris, N. Paillocher, G. Simon, J.-F. Ledigabel, L. Catala & P. Descamps. (2008) Dysménorrhées. EMC - Gynécologie 3:3, pages 1-10.
Crossref
Crossref
Rosa Sabatini, Giuseppe Orsini, Raffaele Cagiano & Giuseppe Loverro. (2007) Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents. Contraception 76:5, pages 342-347.
Crossref
Crossref